.
MergerLinks Header Logo

New Deal


Announced

Completed

ICONIQ Growth completed the $150m investment in Enfusion.

Financials

Edit Data
Transaction Value£110m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

investment management technology

technology services

Acquisition

Domestic

Private

Majority

Single Bidder

Completed

Friendly

United States

Software

Private Equity

Synopsis

Edit

ICONIQ Growth, a tech-focused direct investment effort that is affiliated with ICONIQ Capital, completed the $150m investment in Enfusion, a global company in investment management technology solutions and services. “Our job is to empower and support investment managers wherever they are in their operational journey. As we continue to better position ourselves to meet the needs of our clients, we have worked to remove the silos traditionally associated with portfolio management, order management, trading, operations, accounting, IR, and many other services. ICONIQ shares this vision and we are humbled to have their support in this journey, advancing our commitment to help our clients transform their businesses and grow,” Thomas Kim, Enfusion CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US